Cardio Diagnostics Holdings, Inc. (CDIO)
Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Dr. Meeshanthini V. Dogan Ph.D. | Co-Founder, CEO & Director | 311k | -- | 1989 |
Ms. Elisa Michael Luqman Esq., J.D., M.B.A. | CFO & Principal Accounting Officer | 275k | -- | 1964 |
Mr. Timur Dogan Ph.D. | Chief Technology Officer | 259.17k | -- | 1989 |
Dr. Robert A. Philibert M.D., Ph.D. | Co-Founder, Chief Medical Officer & Director | -- | -- | 1962 |
Ms. Khullani Abdullahi J.D. | Vice President of Revenue & Strategy | -- | -- | 1984 |
Cardio Diagnostics Holdings, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 13
Description
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, including concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
Corporate Governance
Upcoming Events
August 12, 2025 at 8:00 PM UTC - August 16, 2025 at 8:00 PM UTC
Cardio Diagnostics Holdings, Inc. Earnings Date
Recent Events
February 13, 2025 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
December 2, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission